Scholars@Duke publication: Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial.

Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial.

Publication , Journal Article

Al-Khatib, SM; Wojdyla, DM; Granger, CB; Wallentin, L; Garcia, DA; Hijazi, Z; Held, C; Alexander, JH; Vinereanu, D; Flaker, GC; Hylek, EM; Lopes, RD

Published in: Circulation

September 20, 2022

Circulation

1524-4539

September 20, 2022

146

958 / 960

United States

APA

Chicago

ICMJE

MLA

NLM

Al-Khatib, S. M., Wojdyla, D. M., Granger, C. B., Wallentin, L., Garcia, D. A., Hijazi, Z., … Lopes, R. D. (2022). Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial. Circulation, 146(12), 958–960. https://doi.org/10.1161/CIRCULATIONAHA.122.059438

Al-Khatib, Sana M., Daniel M. Wojdyla, Christopher B. Granger, Lars Wallentin, David A. Garcia, Ziad Hijazi, Claes Held, et al. “Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial.” Circulation 146, no. 12 (September 20, 2022): 958–60. https://doi.org/10.1161/CIRCULATIONAHA.122.059438.

Al-Khatib SM, Wojdyla DM, Granger CB, Wallentin L, Garcia DA, Hijazi Z, Held C, Alexander JH, Vinereanu D, Flaker GC, Hylek EM, Lopes RD. Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial. Circulation. 2022 Sep 20;146(12):958–960.